⌘K

Login Start Free

Home/Filings/4/0001209191-10-008676

4//SEC Filing

Standring David 4

Accession 0001209191-10-008676

CIK 0001093649other

View on SEC.gov Company Profile

Filed

Feb 10, 7:00 PM ET

Accepted

Feb 11, 6:14 PM ET

Size

5.8 KB

Accession

0001209191-10-008676

Insider Transaction Report

Form 4

Period: 2010-02-10

IDENIX PHARMACEUTICALS INCIDIX

Standring David

EVP, Biology

Transactions

Award
Employee Stock Option (right to buy)
2010-02-10+50,000→ 50,000 total
Exercise: $2.96Exp: 2020-02-09→ Common Stock (50,000 underlying)

Footnotes (1)

[F1]The option vests in 48 equal monthly installments beginning on February 28, 2010.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

IDENIX PHARMACEUTICALS INC

CIK 0001093649

Entity typeother

Related Parties

1

filerCIK 0001428085

Filing Metadata

Form type: 4
Filed: Feb 10, 7:00 PM ET
Accepted: Feb 11, 6:14 PM ET
Size: 5.8 KB

View on SEC.gov